Back to Results
First PageMeta Content



July 8, 2015 Synergy Pharmaceuticals Appoints Troy Hamilton as Chief Commercial Officer NEW YORK-- Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) today announced that Troy Hamilton has joined the company as Chief Commercial
Add to Reading List

Document Date: 2015-07-08 06:00:03

Open Document

File Size: 37,79 KB

Share Result on Facebook

Company

Johnson & Johnson / McNeil Specialty Products / Shire Pharmaceuticals / Johnson's Janssen Pharmaceuticals / P&L / Inflammatory Bowel Disease / J&J / Synergy Pharmaceuticals Inc. / GI International Marketing / en/ Synergy Pharmaceuticals / /

Country

Belgium / United States / /

/

Event

Employment Change / Product Release / /

Facility

Joseph’s University / /

Holiday

St. Joseph / /

IndustryTerm

biopharmaceutical / care brand management / pharmaceutical industry / pipeline products / pharmaceutical / /

MedicalCondition

Inflammatory Bowel Disease / chronic idiopathic constipation / GI diseases / ulcerative colitis / opioid-induced constipation / constipation / irritable bowel syndrome / disorders / /

Organization

Shire Pharmaceuticals' GI Business Unit / FDA / University of the Sciences in Philadelphia / Securities and Exchange Commission / St. Joseph’s University / /

Person

Troy Hamilton / Gary S. Jacob / /

/

Position

Vice President of GI International Marketing / General Manager / Chairman and CEO / Head of US Marketing / Chief Commercial Officer / representative / general management / Vice President / Product Strategy and Commercial Lead / Private / VP / Investor Relations and Corporate Communications ggokmen@synergypharma.com Source / Vice President / /

Product

Pentasa / Lialda / /

URL

http /

SocialTag